Daniel M. Geynisman, MD | Authors

Daniel M. Geynisman, MD, on Optimal Therapy Selection in RCC

March 11, 2022

At 2022 ASCO GU, Daniel M. Geynisman, MD, spoke with CancerNetwork® about his strategy for treating renal cell carcinoma across lines of therapy.